Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in

Caroline Patry1, Bruno Lemieux, Raymund J Wellinger

  • 1Département de Microbiologie et d'Infectiologie, Faculté de Médecine, Université de Sherbrooke, 3001 12th Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada.

Insights

Heterogeneous nuclear ribonucleoparticle A1 and A2 proteins are essential for the survival of transformed mouse and human cells. Their reduction induces apoptosis in cancer cells but not normal cells, regardless of telomerase activity.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Heterogeneous nuclear ribonucleoparticle (hnRNP) A1 and A2 proteins bind to telomeric sequences.
  • hnRNP A1 levels affect telomere length in human and mouse cells.
  • Previous studies indicated hnRNP A1/A2 knockdown induces apoptosis in human transformed cells but not normal cells.

Purpose of the Study:

  • To investigate the role of hnRNP A1 and A2 proteins in cell viability across different cell types and conditions.
  • To determine if mouse cells exhibit similar responses to hnRNP A1/A2 reduction as human cells.
  • To assess the necessity of hnRNP A1/A2 for the growth of telomerase-negative transformed cells.

Main Methods:

  • Small interfering RNA (siRNA) was used to reduce hnRNP A1 and A2 protein levels in various mouse and human cell lines.
  • Mouse A1 cDNA was expressed in human HeLa cells to assess its protective effect against apoptosis.
  • Cell viability and growth were monitored following protein knockdown.

Main Results:

  • Mouse cell lines showed similar apoptotic responses to hnRNP A1/A2 reduction as observed in human transformed cells.
  • Expression of mouse A1 cDNA conferred protection against apoptosis in human cells undergoing hnRNP A1/A2 knockdown.
  • Knockdown of hnRNP A1/A2 impaired the growth of a human transformed cell line lacking telomerase expression.

Conclusions:

  • hnRNP A1 and A2 proteins are crucial for the viability of both murine and human transformed cells.
  • The requirement for hnRNP A1/A2 is independent of telomerase expression status.
  • These proteins are essential for maintaining the integrity and proliferation of cancer cells, irrespective of telomere length.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.